Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Healey platform data to pave phase III path for Prilenia’s pridopidine: GlobalData
Prilenia Therapeutics presented promising results from the additional analyses of the Phase II Healey ALS Platform Trial…
From policy to progress: Government initiatives impacting India’s lifesciences real estate…
Vishal Goel, MD, RX Propellant
After a harrowing summer, will Bengaluru’s water future change?
As the city continues to face a crisis, industries must focus on sustainable methods of using and discarding water. Using recycled…
Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER…
This product will be manufactured at Lupin’s Pithampur facility in India
Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData
The combination therapy demonstrated significant improvements in seizure control, highlighting its potential as a safe and…
J&J receives full approval from US FDA and European Commission for SIRTURO
With the FDA’s approval, label restrictions that were included when the medicine was granted accelerated approval in the US in…
Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
FDA updates guidance to address spread of misinformation
The revised draft supports the efforts of medical product companies that share this interest in helping the public get factual,…
Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0
Anil Matai, Director General, OPPI shares an optimistic outlook for further enhancements in quality healthcare through continued…